These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 823033)

  • 1. Effects of a xanthine derivative (BL 191) on insulin secretion in normal man.
    Lenti G; Pagano G; Angotzi G; Sani AB; Diana A
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):189-92. PubMed ID: 823033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of secretin on insulin secretion and glucose tolerance.
    Dupré J; Chisholm DJ; McDonald TJ; Rabinovitch A
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1115-21. PubMed ID: 1222379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP infusion and blood sugar, serum insulin and serum nonesterified fatty acid responses to glucose in recent experimental hyperthyroid dogs.
    Renauld A; Garrido D
    Acta Physiol Pharmacol Ther Latinoam; 1992; 42(4):255-76. PubMed ID: 1343982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man.
    Amery CM; Round RA; Smith JM; Nattrass M
    Metabolism; 2000 Apr; 49(4):450-4. PubMed ID: 10778867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
    Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin secretion following carbohydrate administration].
    Förster H
    Z Ernahrungswiss Suppl; 1971; 11():49-57. PubMed ID: 5290595
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans.
    Groop LC; Barzilai N; Ratheiser K; Luzi L; Wåhlin-Boll E; Melander A; DeFronzo RA
    Diabetes Care; 1991 Aug; 14(8):724-7. PubMed ID: 1954808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of gliquidone and glibenclamide following oral administration].
    Ziler T; Waldthaler A; Ermler R; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
    Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
    Carpentier A; Mittelman SD; Bergman RN; Giacca A; Lewis GF
    Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose and galactose infusions in newborns of diabetic and healthy mothers.
    Pribylová J; Kozlová J
    Biol Neonate; 1979; 36(3-4):193-7. PubMed ID: 114240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion.
    Kraegen EW; Lazarus L; Campbell LV
    Metabolism; 1983 Jun; 32(6):622-7. PubMed ID: 6341777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 48-h fat infusion on insulin secretion and glucose utilization.
    Boden G; Chen X; Rosner J; Barton M
    Diabetes; 1995 Oct; 44(10):1239-42. PubMed ID: 7556964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
    Nauck MA; Homberger E; Siegel EG; Allen RC; Eaton RP; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1986 Aug; 63(2):492-8. PubMed ID: 3522621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
    Dobbins RL; Chester MW; Daniels MB; McGarry JD; Stein DT
    Diabetes; 1998 Oct; 47(10):1613-8. PubMed ID: 9753300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
    Boden G; Essa N; Owen OE; Reichle FA
    J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels.
    Luyckx AS; Mendoza E; Lefebvre P
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):305-13. PubMed ID: 7013722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.